Rafferty Asset Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.3 - $1.31 $1,662 - $7,261
5,543 Added 8.68%
69,420 $21,000
Q1 2022

May 13, 2022
BUY
$0.61 - $1.84 $15,131 - $45,643
24,806 Added 63.49%
63,877 $88,000
Q4 2021

Feb 10, 2022
BUY
$1.16 - $2.74 $16,795 - $39,672
14,479 Added 58.88%
39,071 $47,000
Q3 2021

Nov 10, 2021
BUY
$2.62 - $5.43 $64,431 - $133,534
24,592 New
24,592 $64,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email